Effect of DNA-repair-enzyme modulators on cytotoxicity of L-phenylalanine mustard and cis-diamminedichloroplatinum (II) in mammary carcinoma cells resistant to alkylating drugs
- PMID: 8194166
- DOI: 10.1007/BF00685933
Effect of DNA-repair-enzyme modulators on cytotoxicity of L-phenylalanine mustard and cis-diamminedichloroplatinum (II) in mammary carcinoma cells resistant to alkylating drugs
Abstract
We investigated the effect of DNA-repair-enzyme inhibitors on L-phenylalanine mustard (L-PAM) and cis-diamminedichloroplatinum (II) (CDDP) cytotoxicity in rat mammary-carcinoma MatB cells sensitive (WT) and resistant (MLNr) to bifunctional alkylating drugs. Among the modulators tested, the combination of arabinofuranosylcytosine (Ara-C) and hydroxyurea (HU) significantly increased the sensitivity of the cells to CDDP and, to a lesser extent, L-PAM as compared with cells treated with drug alone. The modulation effect of HU+Ara-C on CDDP and L-PAM cytotoxicity was more effective when intracellular glutathione (GSH) was depleted by L-buthionine-(S,R)-sulfoximine (BSO). This was also associated with a significant increase in DNA-DNA interstrand cross-links. Caffeine also sensitized both WT and MLNr cells to the cytotoxic effect of L-PAM and CDDP, and this effect was potentiated in GSH-depleted cells. No significant effect was observed with other repair modulators such as aphidicolin, 3-aminobenzamide, novobiocin, or etoposide. These results show (a) that inhibition of DNA repair by HU+Ara-C or caffeine could be a target for modulation of bifunctional alkylating-drug resistance and (b) that GSH depletion renders resistant cells more susceptible to the repair-enzyme modulators, suggesting that intracellular GSH may be involved in the regulation of some of these enzymes. Our results also indicate that a combination of a number of modulators may offer an advantage over the use of a single modulator in tumor resistance that may be associated with multifactorial mechanisms.
Similar articles
-
Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity.Cancer Chemother Pharmacol. 1992;30(5):341-7. doi: 10.1007/BF00689960. Cancer Chemother Pharmacol. 1992. PMID: 1505071
-
Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.Cancer Res. 1991 Feb 15;51(4):1086-91. Cancer Res. 1991. PMID: 1825474
-
Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.Oncol Res. 1995;7(1):31-8. Oncol Res. 1995. PMID: 7549042
-
Modulation of cis-diamminedichloroplatinum(II) resistance: a review.Br J Cancer. 1992 Aug;66(2):227-38. doi: 10.1038/bjc.1992.249. Br J Cancer. 1992. PMID: 1503895 Free PMC article. Review.
-
Patterns of resistance and therapeutic synergism among alkylating agents.Antibiot Chemother (1971). 1978;23:200-15. doi: 10.1159/000401484. Antibiot Chemother (1971). 1978. PMID: 348078 Review.
Cited by
-
Disruption of mouse SNM1 causes increased sensitivity to the DNA interstrand cross-linking agent mitomycin C.Mol Cell Biol. 2000 Jul;20(13):4553-61. doi: 10.1128/MCB.20.13.4553-4561.2000. Mol Cell Biol. 2000. PMID: 10848582 Free PMC article.
-
A rationally designed genotoxin that selectively destroys estrogen receptor-positive breast cancer cells.J Am Chem Soc. 2002 Mar 6;124(9):1862-3. doi: 10.1021/ja017344p. J Am Chem Soc. 2002. PMID: 11866593 Free PMC article.
-
Combination effects of poly(ADP-ribose) polymerase inhibitors and DNA-damaging agents in ovarian tumor cell lines--with special reference to cisplatin.J Cancer Res Clin Oncol. 1996;122(11):665-70. doi: 10.1007/BF01209029. J Cancer Res Clin Oncol. 1996. PMID: 8898976 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous